Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11793409 | 1.00 | NR1I2 (0.52) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL31275312 | 0.96 | NR1I2 (0.53) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL9183887 | 0.91 | NR1I2 (0.60) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL9183882 | 0.91 | NR1I2 (0.60) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL13394318 | 0.90 | NR1I2 (0.62) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL10300850 | 0.88 | NR1I2 (0.46) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL2683632 | 0.88 | NR1I2 (0.46) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL2683633 | 0.88 | NR1I2 (0.46) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL10902814 | 0.87 | NR1I2 (0.68) | NR1I2PGRADORA3PTGS2PDE4D | |
| SCHEMBL10904416 | 0.87 | NR1I2 (0.68) | NR1I2PGRADORA3PTGS2PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3214168-B1 | SACCHAROMYCES CEREVISIAE CAPABLE OF BEING CO-FERMENTED BY MULTIPLE CARBON SOURCES AND APPLICATION THEREOF | UNIV JIANGNAN (CN) | 2019-08-07 | — | — | EP | claimed |
| EP-3214168-A1 | SACCHAROMYCES CEREVISIAE CAPABLE OF BEING CO-FERMENTED BY MULTIPLE CARBON SOURCES AND APPLICATION THEREOF | Jiangnan University (CN) | 2017-09-06 | — | — | EP | claimed |
| US-12593851-B2 | Leavening agents | PURATOS NV (BE) | 2026-04-07 | — | — | US | disclosed |
| US-20250188201-A1 | CATALYST FOR PHOTOCATALYTIC POLYMERIZATION REACTION, AND APPLICATION THEREOF | BEIJING INSTITUTE OF FASHION TECHNOLOGY (CN) | 2025-06-12 | — | — | US | disclosed |
| CN-112142670-A | Preparation method of caprolactam | 浙江恒澜科技有限公司 | 2020-12-29 | — | — | CN | disclosed |
| CN-112079759-A | Caprolactam production device and production method | 浙江恒澜科技有限公司 | 2020-12-15 | — | — | CN | disclosed |
| EP-3214168-B1 | SACCHAROMYCES CEREVISIAE CAPABLE OF BEING CO-FERMENTED BY MULTIPLE CARBON SOURCES AND APPLICATION THEREOF | UNIV JIANGNAN (CN) | 2019-08-07 | — | — | EP | disclosed |
| US-20190053502-A1 | LEAVENING AGENTS | PURATOS NV (BE) | 2019-02-21 | — | — | US | disclosed |
| US-20180098952-A1 | INACTIVATORS OF TOXOPLASMA GONDII ORNITHINE AMINOTRANSFERASE FOR TREATING TOXOPLASMOSIS AND MALARIA | NORTHWESTERN UNIVERSITY (US) | 2018-04-12 | — | — | US | disclosed |
| EP-3214168-A1 | SACCHAROMYCES CEREVISIAE CAPABLE OF BEING CO-FERMENTED BY MULTIPLE CARBON SOURCES AND APPLICATION THEREOF | Jiangnan University (CN) | 2017-09-06 | — | — | EP | disclosed |
| WO-2017060230-A1 | LEAVENING AGENTS | PURATOS NV (BE) | 2017-04-13 | — | — | WO | disclosed |
| EP-1295875-A1 | HETEROCYCLIC COMPOUNDS | Nippon Shinyaku Co., Ltd. (JP) | 2003-03-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180098952-A1 | INACTIVATORS OF TOXOPLASMA GONDII ORNITHINE AMINOTRANSFERASE FOR TREATING TOXOPLASMOSIS AND MALARIA | OAT, OTC, ABAT | NR1I2 1129/4885PGR 4162/4885ADORA3 1128/4885 |
| US-12593851-B2 | Leavening agents | LCT, CHIA, TREH | NR1I2 4875/4885PGR 4105/4885ADORA3 4631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.